RedHill Biopharma (RDHL) Earnings
|
Expand Research on RDHL
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +15.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +16.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/29/22 | Q222 | -$0.06 | -$0.02 | -$0.04 | $17.6M | $23.19M | N/A |  | | Details | |
| 3/27/23 | Q422 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A | ||
| 2/27/23 | Q322 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A | ||
| 3/6/23 | Q422 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A | ||
| 3/13/23 | Q422 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | N/A | N/A | N/A | $22.75M | N/A | N/A | N/A | ||
| 2/23/23 | Q322 | N/A | $0.00 | N/A | N/A | $18.1M | N/A | N/A | N/A |
